The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Lenvatinib (len) plus pembrolizumab (pembro) for patients (pts) with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor: Updated findings of LEAP-004.
 
Ana Maria Arance
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
Luis de la Cruz-Merino
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Research Funding - Celgene (Inst); Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Teresa M. Petrella
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Sanofi/Regeneron; Sun Pharma
Research Funding - Novartis Canada Pharmaceuticals Inc; Roche Canada
 
Rahima Jamal
No Relationships to Disclose
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - MSD (Inst); Syndax (Inst)
 
Ana Carneiro
Consulting or Advisory Role - Bioinvent; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Alfonso Berrocal
Honoraria - Amgen; BMS; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - BMS; Merck; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - BMS; MSD
 
Ivan Marquez-Rodas
Consulting or Advisory Role - Amgen; AstraZeneca; Bioncotech; Bristol-Myers Squibb; Incyte; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi
Travel, Accommodations, Expenses - Bioncotech; Bristol-Myers Squibb; MSD; Roche
 
Anna Spreafico
Honoraria - Bristol-Myers Squibb; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Oncorus
Research Funding - Alkermes; Array BioPharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Northern Biologics; Novartis; Replimune; Roche; Surface Oncology; Symphogen
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Idera; Janssen Oncology; Merck; Roche
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; QBiotics; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; OncoSec; Pierre Fabre
 
Fernanda Costa Svedman
Employment - Genomic Health (I)
Stock and Other Ownership Interests - Alnylam (I); Cadex Genomics (I); Cantargia AB (I); crispr therapeutics (I); Forty Seven (I); Neurocrine Biosciences (I); Vertex (I)
Consulting or Advisory Role - Cantargia AB (I); Genentech (I); PREMIA (I)
Patents, Royalties, Other Intellectual Property - Genomic Health (I)
(OPTIONAL) Uncompensated Relationships - Cadex Genomics (I)
 
Andrew Mant
No Relationships to Disclose
 
Alan D. Smith
Employment - Eisai
 
Ke Chen
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Scott J. Diede
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Clemens Krepler
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Georgina V. Long
Consulting or Advisory Role - Aduro Biotech; Amgen; Array BioPharma; Boehringer Ingelheim; Bristol-Myers Squibb; Hexal; Highlight Therapeutics; Merck Sharpe & Dohme; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Skyline Diagnostics; Specialised Therapeutics